BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27268447)

  • 1. [Chickenpox and shingles: one virus, two diseases and current vaccination recommendations in Switzerland].
    Eckert N; Masserey Spicher V
    Ther Umsch; 2016; 73(5):247-52. PubMed ID: 27268447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunization of adults against varicella and herpes zoster].
    Hanslik T; Blanchon T; Alvarez FP
    Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella vaccine and infection with varicella-zoster virus.
    Vázquez M; Shapiro ED
    N Engl J Med; 2005 Feb; 352(5):439-40. PubMed ID: 15689581
    [No Abstract]   [Full Text] [Related]  

  • 7. [Varicella vaccination: who should be vaccinated these days?].
    Hügle B; Suchowerskyj P; Schuster V
    MMW Fortschr Med; 2005 Feb; 147(8):31-2, 34-5. PubMed ID: 18441563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of varicella vaccination on herpes zoster incidence.
    Wagenpfeil S; Neiss A; Wutzler P
    Clin Microbiol Infect; 2004 Nov; 10(11):954-60. PubMed ID: 15521996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
    Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
    Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunization against varicella and zoster].
    Floret D
    Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
    Brisson M; Melkonyan G; Drolet M; De Serres G; Thibeault R; De Wals P
    Vaccine; 2010 Apr; 28(19):3385-97. PubMed ID: 20199763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in U.S. Community hospitalizations due to herpes zoster: 2001-2015.
    Pham MA; Bednarczyk RA; Becker ER; Orenstein WA; Omer SB
    Vaccine; 2019 Feb; 37(6):882-888. PubMed ID: 30616954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling and predicting the long-term effects of various strategies and objectives of varicella-zoster vaccination campaigns.
    Riche B; Bricout H; Kürzinger ML; Roche S; Iwaz J; Etard JF; Ecochard R
    Expert Rev Vaccines; 2016 Jul; 15(7):927-36. PubMed ID: 27148763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella and herpes zoster vaccines: WHO position paper, June 2014.
    Wkly Epidemiol Rec; 2014 Jun; 89(25):265-87. PubMed ID: 24983077
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    Wolff E; Widgren K; Scalia Tomba G; Roth A; Lep T; Andersson S
    PLoS One; 2021; 16(5):e0251644. PubMed ID: 33984060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Varicella and herpes zoster. Part 2: therapy and prevention].
    Wittek M; Doerr HW; Allwinn R
    Med Klin (Munich); 2010 Jun; 105(6):399-403. PubMed ID: 20582499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.